Patients with MYC-overexpressing DLBCL had poorer responses to selinexor than those without MYC overexpression, but no data regarding the clinical responses of this drug in patients with HGBCL-DH have been reported18. Here, MYC is linked to dermatitis herpetiformis, familial.